Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sockel, Katja
NCT05237713: Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients	Terminated	2	10	Europe	Canakinumab Injection, Ilaris(R)	University of Leipzig, Novartis Pharmaceuticals	Anemia, Myelodysplastic Syndromes	02/24	02/24
NCT06377462: Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection	Recruiting	N/A	500	Europe		Technische Universität Dresden, Bristol-Myers Squibb, University Hospital Munich	VEXAS Syndrome	12/29	12/30
PRO-RED, NCT05582902: Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients	Recruiting	N/A	60	Europe		University of Leipzig, Deutsche Krebshilfe e.V., Bonn (Germany)	MDS, MDS/MPN	03/25	03/25
Kretschmann, Theresa
NCT05237713: Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients	Terminated	2	10	Europe	Canakinumab Injection, Ilaris(R)	University of Leipzig, Novartis Pharmaceuticals	Anemia, Myelodysplastic Syndromes	02/24	02/24